Drug Alert: CDSCO flags 83 formulations as not of standard quality

Published On 2022-12-15 12:00 GMT   |   Update On 2022-12-15 12:00 GMT

In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 83 medicine batches for failing to qualify for a random drug sample test for the month of November, 2022.These drugs samples which are declared not of standard quality include Pantop-DSR (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged- release...

Login or Register to read the full article

In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 83 medicine batches for failing to qualify for a random drug sample test for the month of November, 2022.

These drugs samples which are declared not of standard quality include Pantop-DSR (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged- release Capsules IP) manufactured by Aristo Pharmaceuticals, SHELCAL-500 (Calcium And Vitamin D3 Tablets I.P.) manufactured by Pure and Cure Healthcare, Paracetamol Tablets IP 650mg manufactured by ANG Lifesciences India, Montelukast Sodium Tablets IP 5 mg manufactured by Skymap Pharmaceuticals and others.

For more details, check out the link given below:

83 Drug Samples Fail To Qualify CDSCO Test


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News